Collaborate Disseminate
Zombie-like cells that have stopped dividing in the human body and accumulate as we age, known as senescent cells, continue to find themselves at the center of all kinds of medical breakthroughs. A new study has explored how these damaged, lingering ce… Continue reading Experimental drugs clear zombie-like cells and apply brakes to diabetes
A new study is proposing blood levels of a specific protein may serve as a useful predictor of type 2 diabetes developing up to two decades before any symptoms appear. The findings indicate a diagnostic blood test could be deployed to offer people a wa… Continue reading Blood biomarker predicts type 2 diabetes risk up to 19 years before onset
Fatty liver disease is a condition linked to obesity and diabetes, and in turn often leads to further major complications. Researchers at the University of Southern California (USC) have now found a way to reverse the progression of the disease in mice… Continue reading Experimental therapy reverses obesity-induced liver damage in mice
If you or someone you know is diabetic, it is a good bet that a glucose meter is a regular fixture in your life. They are cheap and plentiful, but …read more Continue reading Tech in Plain Sight: Glucose Meters
Currently, most diabetics have to check their blood glucose levels by performing finger-prick blood tests, or via subdermal implanted sensors. An experimental new device, however, could someday do the job while simply adhered to the surface of the user… Continue reading Skin-adhered sensor tracks blood glucose levels via its wearer’s sweat
A new study analyzing health records from several hundred thousand people in Denmark has identified a link between low rates of type 2 diabetes and osteoporosis patients treated with a drug called alendronate. The researchers hypothesize the drug may p… Continue reading Reduced risk of type 2 diabetes linked to cheap, common osteoporosis drug
The human body contains a number of different types of fat, and one with particularly insidious effects is visceral fat, which can be found deep inside the abdominal cavity. These deep-lying fat stores wrap around the organs and are linked to a range o… Continue reading Study pinpoints “interpreter” cells that trigger burning of deep fat
When you’ve got a diabetic in your life, there are few moments in any day that are free from thoughts about insulin. Insulin is literally the first coherent thought I …read more Continue reading Open-Source Insulin: Biohackers Aiming for Distributed Production
A team of scientists in the US investigating the relationship between metabolic syndrome and a key hormone have demonstrated how a promising new drug could play an important preventative role in a variety of conditions. The experiments were carried out… Continue reading Novel anti-obesity drug breaks the cycle of appetite and weight gain
A new study published in the journal Neurology is reporting an association between a particular class of drugs used to treat type 2 diabetes and decreased Alzheimer’s disease biomarkers. It is unclear exactly how these diabetes drugs could exert neuroprotective effects, but Alzheimer’s experts are calling for large-scale clinical trials to explore these potential treatments in non-diabetic groups.
Tags: Diabetes, Dementia, Alzheimer’s Disease, Brain, Neuroscience, New Atlas Audio
Continue reading New research suggests diabetes drug could slow Alzheimer’s progression